Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: The emergence of new variants of concern (VOCs) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) around the world significantly complicated the exit from Coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to evaluate the serum neutralizing activity of three cohorts.
Methods: BNT162b2-elicited serum (N = 103), candidates as hyper-immune plasma donors (N = 90) and patients infected with the SARS-CoV-2 P1 variant (N = 22) were enrolled. Three strains of SARS-CoV-2 have been tested: 20A.EU1, B.1.1.7 (alpha) and P.1 (gamma). Neutralizing antibodies (NT-Abs) titers against SARS-CoV-2 were evaluated.
Results: B.1.1.7 and P.1 are less efficiently neutralized by convalescent wild-type infected serums if compared to 20A.EU1 strain (mean titer 1.6 and 6.7-fold lower respectively). BNT162b2 vaccine-elicited human sera show an equivalent neutralization potency on the B.1.1.7 but it is significantly lower for the P.1 variant (mean titer 3.3-fold lower). Convalescent P.1 patients are less protected from other SARS-CoV-2 strains with an important reduction of neutralizing antibodies against 20A.EU1 and B.1.1.7, about 12.2 and 10.9-fold, respectively.
Conclusions: BNT162b2 vaccine confers immunity against all the tested VOCs, while previous SARS-CoV-2 infection may be less protective.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310664 | PMC |
| http://dx.doi.org/10.1016/j.jinf.2021.07.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing SARS-CoV-2 Rare Mutations and Transmission in New York City by NGS.
Microorganisms
August 2025
Department of Pathology and Clinical Laboratories, New York-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
SARS-CoV-2 undergoes frequent mutations that drive viral evolution and genomic diversity, influencing transmissibility, immune escape, and disease severity. In this study, we performed whole-genome sequencing on SARS-CoV-2 isolates from patients in New York City and identified several globally rare mutations across multiple viral lineages. The isolates analyzed for rare mutations belonged to three lineages: B.
View Article and Find Full Text PDFSARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression.
Viruses
August 2025
Institute of Virology, Medical Center University of Freiburg, 79104 Freiburg, Germany.
Human leukocyte antigen class I (HLA-I) molecules present intracellular peptides on the cell surface to enable CD8+ T cells to effectively control viral infections. Many viruses disrupt this antigen presentation pathway to evade immune detection. In this study, we demonstrate that SARS-CoV-2 Nsp1 impairs both the constitutive and interferon-γ (IFN-γ)-induced upregulation of HLA-I.
View Article and Find Full Text PDFMultiplex RT-qPCR strategy for SARS-CoV-2 variants detection in developing countries without ngs: The Bolivian experience.
Epidemiol Infect
August 2025
Department of Pediatric Infectious Diseases and Immunology, School of Medicine, https://ror.org/04teye511Pontificia Universidad Católica de Chile, Santiago, Chile.
The rapid evolution of SARS-CoV-2 has led to the emergence of variants of concern (VOCs) characterized by increased transmissibility, pathogenicity, and resistance to neutralizing antibodies. Identifying these variants is essential for guiding public health efforts to control COVID-19. Although whole genome sequencing (WGS) is the gold standard for variant identification, its implementation is often limited in developing countries due to resource constraints.
View Article and Find Full Text PDFNanopore sequencing reveals the genomic diversity of the variants of concern of SARS-CoV-2 during 2021 disease outbreak in Pakistan.
Sci Rep
August 2025
Microbiological Analysis Team, Korea Research Institute of Standards and Science (KRISS), Daejeon, 34113, Republic of Korea.
The global spread of SARS-CoV-2 was significantly impacted by the emergence of Variants of Concern (VOC), with Pakistan experiencing similar trends to other countries. To gain a comprehensive understanding of the genomic epidemiology of SARS-CoV-2 strains circulating during Pakistan's third and fourth pandemic waves, we conducted the largest single sequencing effort in the country to date. Using the GridION platform (Oxford Nanopore Technologies), we performed whole genome sequencing on 1052 confirmed COVID-19 patient samples collected from multiple cities across Pakistan between March and October 2021.
View Article and Find Full Text PDFPhylogenetic insights into the early spread of the SARS-CoV-2 Alpha variant across Europe.
Virus Evol
June 2025
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
The evolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has profoundly influenced the trajectory of the COVID-19 pandemic. In late 2020, the Alpha variant (Pango lineage B.1.
View Article and Find Full Text PDF